Management of Cytomegalovirus Infection in Lung Transplant Recipients: Evidence-Based Recommendations

Abstract
Cytomegalovirus (CMV) continues to cause significant morbidity and mortality in lung transplant recipients. This article presents recommendations based on available evidence for the optimal management of CMV in lung transplant recipients, which have been developed by an expert committee of transplant physicians-surgeons and infectious disease specialists.

This publication has 36 references indexed in Scilit: